-
1
-
-
33746884732
-
-
Wolters Kluwer Health St. Louis
-
Sewester CS, Dombek CE, Olin BR, Kastrup EK, Hebel SK (2004) Drug facts and comparisons. Wolters Kluwer Health, St. Louis
-
(2004)
Drug Facts and Comparisons
-
-
Sewester, C.S.1
Dombek, C.E.2
Olin, B.R.3
Kastrup, E.K.4
Hebel, S.K.5
-
2
-
-
67349202148
-
The top 200 prescription drugs of 2006
-
Accessed February 21, 2008
-
Pharmacy Times (2008) The top 200 prescription drugs of 2006. Available from URL: http://www.pharmacytimes.com/issues/articles/2007-05-4629.asp. Accessed February 21, 2008
-
(2008)
Pharmacy Times
-
-
-
3
-
-
0030024585
-
Carcinogenicity of lipid-lowering drugs
-
10.1001/jama.275.1.55
-
TB Newman SB Hulley 1996 Carcinogenicity of lipid-lowering drugs JAMA 275 55 60 10.1001/jama.275.1.55
-
(1996)
JAMA
, vol.275
, pp. 55-60
-
-
Newman, T.B.1
Hulley, S.B.2
-
4
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators
-
10.1056/NEJM199610033351401
-
FM Sacks MA Pfeffer LA Moye 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators N Engl J Med 335 1001 1009 10.1056/NEJM199610033351401
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
5
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
-
10.1016/S0140-6736(02)11600-X
-
J Shepherd GJ Blauw MB Murphy 2002 Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 1623 1630 10.1016/S0140-6736(02)11600-X
-
(2002)
Lancet
, vol.360
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
-
6
-
-
0036239832
-
HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis
-
DOI 10.1038/sj/leu/2402476
-
WW Wong J Dimitroulakos MD Minden LZ Penn 2002 HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 508 519 10.1038/sj.leu.2402476 (Pubitemid 34460459)
-
(2002)
Leukemia
, vol.16
, Issue.4
, pp. 508-519
-
-
Wong, W.W.-L.1
Dimitroulakos, J.2
Minden, M.D.3
Penn, L.Z.4
-
8
-
-
0034726387
-
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: A nested case-control study
-
10.1001/archinte.160.15.2363
-
L Blais A Desgagne J LeLorier 2000 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study Arch Intern Med 160 2363 2368 10.1001/archinte.160.15.2363
-
(2000)
Arch Intern Med
, vol.160
, pp. 2363-2368
-
-
Blais, L.1
Desgagne, A.2
Lelorier, J.3
-
9
-
-
1542329169
-
Statin use and cancer risk in the General Practice Research Database
-
10.1038/sj.bjc.6601566
-
JA Kaye H Jick 2004 Statin use and cancer risk in the General Practice Research Database Br J Cancer 90 635 637 10.1038/sj.bjc.6601566
-
(2004)
Br J Cancer
, vol.90
, pp. 635-637
-
-
Kaye, J.A.1
Jick, H.2
-
10
-
-
33847031748
-
Statin use and the risk of 10 cancers
-
10.1097/01.ede.0000254694.03027.a1
-
PF Coogan L Rosenberg BL Strom 2007 Statin use and the risk of 10 cancers Epidemiology 18 213 219 10.1097/01.ede.0000254694.03027.a1
-
(2007)
Epidemiology
, vol.18
, pp. 213-219
-
-
Coogan, P.F.1
Rosenberg, L.2
Strom, B.L.3
-
11
-
-
14844292583
-
Cancer risk among statin users: A population-based cohort study
-
10.1002/ijc.20758
-
S Friis AH Poulsen SP Johnsen 2005 Cancer risk among statin users: a population-based cohort study Int J Cancer 114 643 647 10.1002/ijc.20758
-
(2005)
Int J Cancer
, vol.114
, pp. 643-647
-
-
Friis, S.1
Poulsen, A.H.2
Johnsen, S.P.3
-
12
-
-
38649095993
-
Screening statins for possible carcinogenic risk: Up to 9 years of follow-up of 361,859 recipients
-
10.1002/pds.1507
-
GD Friedman ED Flick N Udaltsova J Chan CP Quesenberry Jr LA Habel 2008 Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients Pharmacoepidemiol Drug Saf 17 27 36 10.1002/pds.1507
-
(2008)
Pharmacoepidemiol Drug Saf
, vol.17
, pp. 27-36
-
-
Friedman, G.D.1
Flick, E.D.2
Udaltsova, N.3
Chan, J.4
Quesenberry Jr, C.P.5
Habel, L.A.6
-
14
-
-
48149114863
-
Statin use and prostate cancer risk in a large population based setting
-
10.1007/s10552-008-9139-4
-
DM Boudreau O Yu DS Buist DL Miglioretti 2008 Statin use and prostate cancer risk in a large population based setting Cancer Causes Control 19 767 774 10.1007/s10552-008-9139-4
-
(2008)
Cancer Causes Control
, vol.19
, pp. 767-774
-
-
Boudreau, D.M.1
Yu, O.2
Buist, D.S.3
Miglioretti, D.L.4
-
15
-
-
0025113278
-
Revisions in the risk-based breast cancer screening program at Group Health Cooperative
-
10.1002/1097-0142(19900815)66:4<812::AID-CNCR2820660436>3.0.CO;2-1
-
SH Taplin RS Thompson F Schnitzer C Anderman V Immanuel 1990 Revisions in the risk-based breast cancer screening program at Group Health Cooperative Cancer 66 812 818 10.1002/1097-0142(19900815)66:4<812::AID- CNCR2820660436>3.0.CO;2-1
-
(1990)
Cancer
, vol.66
, pp. 812-818
-
-
Taplin, S.H.1
Thompson, R.S.2
Schnitzer, F.3
Anderman, C.4
Immanuel, V.5
-
16
-
-
84889387923
-
Group health cooperative
-
4 Wiley Chichester
-
Saunders KW, Davis RL, Stergachis A (2005) Group health cooperative. In: Strom B (ed) Pharmacoepidemiology, 4th edn. Wiley, Chichester, pp 223-239
-
(2005)
Pharmacoepidemiology
, pp. 223-239
-
-
Saunders, K.W.1
Davis, R.L.2
Stergachis, A.3
Strom, B.4
-
18
-
-
3042798873
-
A population-based osteoporosis screening program: Who does not participate, and what are the consequences?
-
10.1111/j.1532-5415.2004.52311.x
-
DS Buist AZ LaCroix SK Brenneman T Abbott 2004 A population-based osteoporosis screening program: who does not participate, and what are the consequences? J Am Geriatr Soc 52 1130 1137 10.1111/j.1532-5415.2004.52311.x
-
(2004)
J Am Geriatr Soc
, vol.52
, pp. 1130-1137
-
-
Buist, D.S.1
Lacroix, A.Z.2
Brenneman, S.K.3
Abbott, T.4
-
19
-
-
1242314300
-
Evaluating organized breast cancer screening implementation: The prevention of late-stage disease?
-
10.1158/1055-9965.EPI-03-0206
-
SH Taplin L Ichikawa DS Buist D Seger E White 2004 Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev 13 225 234 10.1158/1055-9965.EPI-03-0206
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, pp. 225-234
-
-
Taplin, S.H.1
Ichikawa, L.2
Buist, D.S.3
Seger, D.4
White, E.5
-
20
-
-
67349215121
-
-
Washington State Department of Health, Center for Health Statistics Accessed February 21, 2008
-
Washington State Department of Health, Center for Health Statistics (2008) Washington State vital statistics 2005. Available from URL: http://www.doh.wa.gov/ehsphl/chs/chs-data/public/AnnSum-2005.pdf. Accessed February 21, 2008
-
(2008)
Washington State Vital Statistics 2005
-
-
-
21
-
-
0033051865
-
The use of automated data to identify complications and comorbidities of diabetes: A validation study
-
10.1016/S0895-4356(98)00161-9
-
KM Newton EH Wagner SD Ramsey 1999 The use of automated data to identify complications and comorbidities of diabetes: a validation study J Clin Epidemiol 52 199 207 10.1016/S0895-4356(98)00161-9
-
(1999)
J Clin Epidemiol
, vol.52
, pp. 199-207
-
-
Newton, K.M.1
Wagner, E.H.2
Ramsey, S.D.3
-
23
-
-
0003684449
-
-
Springer New York
-
Hastie T, Tibshirani R, Friedman J (eds) (2001) The elements of statistical learning; data mining, inference, and prediction. Springer, New York
-
(2001)
The Elements of Statistical Learning; Data Mining, Inference, and Prediction
-
-
Hastie, T.1
Tibshirani, R.2
Friedman, J.3
-
24
-
-
34250693757
-
Statins and cancer
-
10.1097/EDE.0b013e3180646718
-
P Coogan L Rosenberg B Strom 2007 Statins and cancer Epidemiology 18 520 521 10.1097/EDE.0b013e3180646718
-
(2007)
Epidemiology
, vol.18
, pp. 520-521
-
-
Coogan, P.1
Rosenberg, L.2
Strom, B.3
-
25
-
-
0026698298
-
Risk factors, epidemiology, screening, and prognostic factors in female genital cancer
-
10.1097/00001622-199210000-00016
-
M Friedlander P de Souza E Segelov 1992 Risk factors, epidemiology, screening, and prognostic factors in female genital cancer Curr Opin Oncol 4 913 922 10.1097/00001622-199210000-00016
-
(1992)
Curr Opin Oncol
, vol.4
, pp. 913-922
-
-
Friedlander, M.1
De Souza, P.2
Segelov, E.3
|